XML 17 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stockholder's Equity (Tables)
12 Months Ended
Mar. 31, 2015
Stockholders' Equity  
Schedule of Share Based Payment Award Stock Options and Employee Stock Purchase Plan Valuation Assumptions

 

 

 

 

Years Ended March 31,

 

 

 

2015

 

2014

 

 

 

 

 

ESPP

 

 

 

ESPP

 

 

 

Stock

 

purchase

 

Stock

 

purchase

 

 

 

options

 

rights

 

options

 

rights

 

Expected term

 

5.57 

 

0.5 Years

 

5.67 Years

 

0.5 Years

 

Expected volatility

 

77 

%

84 

%

77 

%

76 

%

Risk-free interest rate

 

1.73 

%

0.07 

%

1.56 

%

0.08 

%

Dividend yield

 

%

%

%

%

 

Schedule Of Share Based Compensation Stock Options Activity

Total stock-based compensation expense included in the consolidated statements of comprehensive loss is as follows (in thousands):

 

 

 

Twelve Months Ended March 31,

 

 

 

2015

 

2014

 

 

 

 

 

 

 

Cost of service revenue

 

$

23 

 

$

39 

 

Operating expense:

 

 

 

 

 

Selling and marketing

 

53 

 

347 

 

Research and development

 

114 

 

285 

 

General and administrative

 

411 

 

410 

 

 

 

 

 

 

 

Total stock-based compensation expense

 

601 

 

1,081 

 

Income tax benefit

 

 

 

 

 

 

 

 

 

Net stock-based compensation expense

 

$

601 

 

$

1,081 

 

 

 

 

 

 

 

 

 

 

Schedule of stock option activity

 

 

 

 

Number of Shares

 

Weighted
Average
Exercise Price

 

Weighted
Average
Remaining
Contractual
Term in Years

 

Aggregate
Intrinsic Value

 

 

 

 

 

 

 

 

 

 

 

Options outstanding as of March 31, 2014

 

3,409,433

 

$

2.41

 

7.0

 

$

221,097

 

Granted

 

3,203,000

 

$

0.78

 

 

 

 

 

Exercised

 

(22,542

)

$

0.70

 

 

 

 

 

Forfeited

 

(1,305,036

)

$

1.27

 

 

 

 

 

Expired

 

(654,033

)

$

2.40

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options outstanding as of March 31, 2015

 

4,630,822

 

$

1.61

 

7.6

 

$

2,575

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at March 31, 2015

 

4,019,928

 

$

1.75

 

7.3

 

$

1,770

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at March 31, 2015

 

2,083,884

 

$

2.59

 

5.3

 

$